Michael Kelly, PA
Physician Assistant · Tulsa, OKNPI 1740366111
Payments from drug & device makers
Across 359 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Sumitomo Pharma America, Inc.$1K
- Astellas Pharma US Inc$565
- AbbVie$479
- Urovant Sciences Inc$308
- Coloplast$297
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,95291%
- Education$4859%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 44 | $1,007 |
| Sumitomo Pharma America, Inc. | 141 | $1,004 |
| Astellas Pharma US Inc | 21 | $565 |
| AbbVie(2 entities) | 32 | $479 |
| Urovant Sciences Inc | 22 | $308 |
| Coloplast | 15 | $297 |
| Pfizer | 12 | $269 |
| Myriad Genetic Laboratories, Inc. | 12 | $223 |
| Intuitive Surgical | 2 | $168 |
| Ferring Pharmaceuticals Inc. | 5 | $107 |
| Endo Pharmaceuticals Inc. | 7 | $104 |
| Bayer | 4 | $84 |
| Myovant Sciences Inc. | 4 | $80 |
| Boston Scientific | 5 | $78 |
| Medtronic | 3 | $62 |
| Urogen Pharma, Inc. | 3 | $58 |
| Endo USA, Inc. | 3 | $52 |
| 180 Medical, Inc. | 2 | $50 |
| Teleflex LLC | 2 | $45 |
| Antares Pharma, Inc. | 2 | $43 |
| Travere Therapeutics, Inc. | 2 | $42 |
| Blue Earth Diagnostics | 2 | $38 |
| Immunitybio, Inc. | 2 | $35 |
| Merck | 2 | $35 |
| Novartis | 1 | $31 |
| Vertex | 1 | $29 |
| Progenics Pharmaceuticals, Inc. | 1 | $25 |
| Civco Medical Instruments | 1 | $24 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Hollister Incorporated | 1 | $18 |
| Dendreon Pharmaceuticals LLC | 1 | $18 |
| Accord Healthcare, Inc. | 1 | $17 |
| Halozyme Inc | 1 | $13 |
| Convatec Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$100
How this compares
$5,437 in reported general payments places this provider in the 90th percentile of 1,491 physician assistant providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 58 | $55,235 |
| MyrbetriqMirabegron | 49 | $48,523 |
| Tamsulosin Hcl | 282 | $6,053 |
| Finasteride | 103 | $1,905 |
| Silodosin | 14 | $923 |
| Oxybutynin Chloride ErOxybutynin Chloride | 33 | $789 |
| Oxybutynin Chloride | 25 | $496 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 19 | $491 |
| Estradiol | 13 | $487 |
| Cephalexin | 44 | $477 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $433 |
| Ciprofloxacin Hcl | 26 | $209 |
| Testosterone Cypionate | 13 | $200 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $131 |
| Tramadol Hcl | 20 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $1,004 | $55,23558 claims |
| Astellas Pharma US IncMyrbetriq | $565 | $48,52349 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,491 physician assistant providers in Oklahoma.
Other physician assistant in Tulsa
- Matthew PattonTulsa$24K
- Michelle GreenTulsa$18K
- Muge ParkTulsa$17K
- Rose RamirezTulsa$15K
- Melissa RohrerTulsa$14K
- Jenny BirksTulsa$13K
- Andrea BellassaiTulsa$12K
- Jennifer ComptonTulsa$12K
- Adrian DonnellyTulsa$12K
- Valerie TerrellTulsa$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.